The main purpose in the trial was to determine if Anastrozole could extend the length of “condition-cost-free survival” for that collaborating individuals. Illness-free of charge survival is defined given that the interval after drugs and/or treatments are stopped before the patient’s cancer returns. Over the demo, researchers tracked events